首页> 外文期刊>The Lancet >Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1.
【24h】

Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1.

机译:胰岛素抵抗:肥胖与胰岛素受体底物1的常见变异之间的相互作用。

获取原文
获取原文并翻译 | 示例
           

摘要

We previously discovered two aminoacid polymorphisms in codons 513 and 972 of the protein insulin receptor substrate-1 (IRS-1), which is important in cellular insulin action. We have investigated whether these polymorphisms are associated with changes in insulin sensitivity in a random sample of young healthy adults. Insulin sensitivity and secretion were measured during a combined intravenous glucose and tolbutamide tolerance test in 380 unrelated white subjects aged 18-32. IRS-1 polymorphisms were examined by single-strand conformation polymorphism and verified by restriction-enzyme digestion. No homozygous carrier of the codon-513 variant was identified, but one non-obese man had the codon-972 mutation on both alleles. He had low fasting-serum insulin and C-peptide concentrations and low insulin sensitivity and glucose effectiveness. During a 24 h dexamethasone test, he developed transient diabetes. In their heterozygous forms the codon-513 and codon-972 variants of IRS-1 were found in 3% and 9% of the subjects. Non-obese carriers of either polymorphism had similar insulin sensitivity and pancreatic beta-cell function to non-obese wild-type subjects (no known variants of IRS-1). Analysis of variance showed, however, a significant interaction between obesity (body-mass index > or = 25 kg/m2) and the heterozygous form of the codon-972 variant (p < 0.003); obese polymorphism carriers had lower insulin sensitivity than obese non-carriers (mean 6.0 [SD 3.3] vs 12.3 [9.5] x 10(-5) L min-1 pmol-1). The obese carriers of the codon-972 variant were also characterised by a clustering of metabolic cardiovascular risk factors, with raised fasting concentrations of plasma glucose, serum triglyceride, and plasma tissue-plasminogen-activator and its fast-acting inhibitor. With adjustment for known modulators of insulin sensitivity, multivariate analyses showed that the combination of obesity and the codon-972 variant was associated with a 50% reduction in insulin sensitivity (p = 0.0008). Our results suggest that the codon-972 IRS-1 gene variant may interact with obesity in the pathogenesis of common insulin-resistant disorders.
机译:我们先前在蛋白质胰岛素受体底物1(IRS-1)的513和972密码子中发现了两个氨基酸多态性,这在细胞胰岛素作用中很重要。我们已经调查了这些多态性是否与年轻健康成年人的随机样本中胰岛素敏感性的变化有关。在380名年龄在18-32岁的白人中,对静脉葡萄糖和甲苯磺丁酰胺的联合耐受性测试期间测量了胰岛素敏感性和分泌。 IRS-1多态性通过单链构象多态性进行检查,并通过限制性内切酶消化进行验证。没有鉴定出密码子513变体的纯合子携带者,但一名非肥胖男子在两个等位基因上均具有密码子972突变。他的空腹血清胰岛素和C肽浓度低,胰岛素敏感性和葡萄糖有效性低。在地塞米松24小时测试中,他患上了短暂性糖尿病。在其杂合体形式中,IRS-1的密码子513和972的变体在3%和9%的受试者中被发现。具有非多态性的非肥胖携带者具有与非肥胖野生型受试者相似的胰岛素敏感性和胰岛β细胞功能(IRS-1尚无已知变体)。方差分析显示,肥胖(体质指数>或= 25 kg / m2)与密码子972变体的杂合子形式之间存在显着的相互作用(p <0.003)。肥胖多态性携带者的胰岛素敏感性低于肥胖非携带者(平均6.0 [SD 3.3]与12.3 [9.5] x 10(-5)L min-1 pmol-1)。密码子-972变体的肥胖携带者的特征还在于代谢性心血管危险因素的聚集,其空腹血糖浓度,血清甘油三酸酯,血浆组织纤溶酶原激活剂及其速效抑制剂的空腹浓度升高。通过调整已知的胰岛素敏感性调节剂,多变量分析表明,肥胖症和密码子-972变体的组合可使胰岛素敏感性降低50%(p = 0.0008)。我们的结果表明,密码子-972 IRS-1基因变异可能与肥胖在常见的胰岛素抵抗性疾病的发病机理中相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号